0
Comment(s)
*
* The moderation of comments is automated and not cleared manually by indianexpress.com.
In this Friday, May 28, 2021 file photo, a healthcare worker prepares a dose of the Sinovac COVID-19 vaccine during a vaccination session for medical staff who work at private clinics in Caracas, Venezuela. (AP) The World Health Organization (WHO) has approved a Covid-19 vaccine made by Sinovac Biotech for emergency use listing, the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product’s safety and efficacy. It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems due to India’s suspension of vaccine exports.
Test tubes are seen in front of a displayed Sinovac logo in this illustration taken, May 21, 2021. (Reuters)
In a statement, the independent panel of experts said it recommended Sinovac’s vaccine for adults over 18, with a second dose 2-4 weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
